Back to results
US 2021/0330812 A1Published application
Treatment of retinal degeneration using gene therapy
AssigneeThe University of Manchester
InventorsRobert Lucas, Paul Bishop, Jasmina Cehajic-Kapetanovic
Life of this patent
Estimating the term…
Abstract
The present invention relates to an improved method of providing photoreceptor function to a cell, for example for use in the treatment of retinal degeneration. The present invention also relates to compositions and kits, in particular for use in such methods.
Claims28
1-81. (canceled)
82-90. (canceled)
A composition comprising a nucleic acid vector comprising a nucleic acid sequence encoding a human rhodopsin or a human photopsin, wherein the nucleic acid is under control of a promoter which directs expression of said nucleic acid to an inner retinal cell in a subject with a condition.
Dependencies are inferred from the claim text.